These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25657978)

  • 1. Extracapillary proliferation in IgA nephropathy; recent findings and new ideas.
    Nasri H; Mubarak M
    J Nephropathol; 2015 Jan; 4(1):1-5. PubMed ID: 25657978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining.
    Ştefan G; Ismail G; Stancu S; Zugravu A; Andronesi A; Mandache E; Mircescu G
    Pathol Int; 2016 Aug; 66(8):453-9. PubMed ID: 27439692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of extracapillary proliferation in IgA-nephropathy patients with regard to clinical and histopathological variables.
    Rafieian-Kopaei M; Baradaran A; Nasri H
    Hippokratia; 2013 Jul; 17(3):258-61. PubMed ID: 24470738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxford-MEST classification in IgA nephropathy patients: A report from Iran.
    Nasri H; Mortazavi M; Ghorbani A; Shahbazian H; Kheiri S; Baradaran A; Emami-Naieni A; Saffari M; Mardani S; Momeni A; Madihi Y; Baradaran-Ghahfarokhi M; Rafieian-Kopaie M; Hedayati P; Baradaran S; Ardalan M; Sajjadieh S; Assarzadegan N; Ahmadi Soleimani SM; Tamadon MR
    J Nephropathol; 2012 Apr; 1(1):31-42. PubMed ID: 24475384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation.
    Katafuchi R; Ninomiya T; Nagata M; Mitsuiki K; Hirakata H
    Clin J Am Soc Nephrol; 2011 Dec; 6(12):2806-13. PubMed ID: 22157710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
    Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
    Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients.
    Zeng CH; Le W; Ni Z; Zhang M; Miao L; Luo P; Wang R; Lv Z; Chen J; Tian J; Chen N; Pan X; Fu P; Hu Z; Wang L; Fan Q; Zheng H; Zhang D; Wang Y; Huo Y; Lin H; Chen S; Sun S; Wang Y; Liu Z; Liu D; Ma L; Pan T; Zhang A; Jiang X; Xing C; Sun B; Zhou Q; Tang W; Liu F; Liu Y; Liang S; Xu F; Huang Q; Shen H; Wang J; Shyr Y; Phillips S; Troyanov S; Fogo A; Liu ZH
    Am J Kidney Dis; 2012 Nov; 60(5):812-20. PubMed ID: 22819700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
    Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
    Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.
    Le W; Zeng CH; Liu Z; Liu D; Yang Q; Lin RX; Xia ZK; Fan ZM; Zhu G; Wu Y; Xu H; Zhai Y; Ding Y; Yang X; Liang S; Chen H; Xu F; Huang Q; Shen H; Wang J; Fogo AB; Liu ZH
    BMC Nephrol; 2012 Nov; 13():158. PubMed ID: 23181565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare.
    Hisano S; Joh K; Katafuchi R; Shimizu A; Hashiguchi N; Kawamura T; Matsuo S;
    Clin Exp Nephrol; 2017 Feb; 21(1):92-96. PubMed ID: 27011013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological differences in new-onset IgA nephropathy between children and adults.
    Ikezumi Y; Suzuki T; Imai N; Ueno M; Narita I; Kawachi H; Shimizu F; Nikolic-Paterson DJ; Uchiyama M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3466-74. PubMed ID: 16935895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric IgA Nephropathy in Europe.
    Coppo R
    Kidney Dis (Basel); 2019 Jun; 5(3):182-188. PubMed ID: 31259180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracapillary proliferation is an independent predictive factor in Immunoglobulin A nephropathy.
    Serriello I; Polci R; Feriozzi S; Gigante A; Di Giulio S; Rosa M; Galliani M; Morosetti M; Pugliese F; Petitti T; Onetti Muda A; Giannakakis K
    Nephrology (Carlton); 2015 Sep; 20(9):654-9. PubMed ID: 25943286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of crescent formation as a predictive marker in immunoglobulin A nephropathy: a systematic review and meta-analysis.
    Shao X; Li B; Cao L; Liang L; Yang J; Wang Y; Feng S; Wang C; Weng C; Shen X; Jiang H; Chen J
    Oncotarget; 2017 Jul; 8(28):46436-46448. PubMed ID: 28526805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy.
    Coppo R; Davin JC
    Pediatr Nephrol; 2015 Feb; 30(2):189-92. PubMed ID: 25318618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Significance of Crescents on the Clinical Features and Outcomes of Primary Immunoglobin A Nephropathy.
    Du Y; Chen S; Wang F; Zhang P; Liu M; Liu C; Zhong X; Qin J; Li G; Wang W
    Front Med (Lausanne); 2022; 9():864667. PubMed ID: 35847826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
    Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.